Jazz Pharmaceuticals ROE - Return on Equity 2010-2024 | JAZZ

Jazz Pharmaceuticals return on equity for the quarter ending September 30, 2024 was 12.7.

  • Jazz Pharmaceuticals average return on equity for 2023 was 1.74, a 133.98% increase from 2022.
  • Jazz Pharmaceuticals average return on equity for 2022 was -5.12, a 695.35% decline from 2021.
  • Jazz Pharmaceuticals average return on equity for 2021 was 0.86, a 87.18% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

Jazz Pharmaceuticals ROE - Return on Equity 2010-2024 | JAZZ

  • Jazz Pharmaceuticals average return on equity for 2023 was 1.74, a 133.98% increase from 2022.
  • Jazz Pharmaceuticals average return on equity for 2022 was -5.12, a 695.35% decline from 2021.
  • Jazz Pharmaceuticals average return on equity for 2021 was 0.86, a 87.18% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.